m
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
on the left hand side...is there an option to switch to "classic view"?
http://www.investorshub.com/boards/read_msg.asp?message_id=15348475
control panel, Administrative Tools
I agree with ya, but the funny thing to me is, TV, radio or the Internet, is nothing compared to what they hear and see at school, whether its public or parochial, maybe next they will blind ,gag and cover the ears of our kids while they are at school.
OT: this is a test sponsored by the Cleveland Clinic, it was a real eye opener for me, I plan on following there recommendation's to change my health
http://www.realage.com/
OT: this is a test sponsored by the Cleveland Clinic, it was a real eye opener for me, I plan on following there recommendation's to change my health
http://www.realage.com/
don't forget to take it out of your favorites
I just deleted 2 post that I thought were personal attacks, please stay on topic, if you have any complaints on the removal please PM Matt the administrator of this site.
http://www.investorshub.com/boards/profile.asp?user=2744
stocks4john my pick is Cincinnati
thanks
thanks, I am going put those numbers in the IBOX and try to call at least once a month
painesville
is this the correct
A/S 250,000,000
O/S 153,750,000
Press Release Source: Modern Technology Corp
Modern Technology Corp Announces Stock-Dividend and Subsidiary Spin-Off
Monday December 4, 10:53 am ET
OXFORD, Miss., Dec. 4, 2006 (PRIME NEWSWIRE) -- Modern Technology Corp (Other OTC:MODC.PK - News), a diversified technology development and acquisition company, announced today its stock dividend date and details of it planned spin-off of its subsidiary, Inmarketing Group.
Stock Dividend:
On January 5th, 2007, all shareholders of record will receive shares in Inmarketing, pro rata, to their ownership in MODC. Stockholders will retain all current ownership in MODC and will receive new shares in Inmarketing in proportion to their ownership in MODC.
Spin-Off:
On Wednesday, Nov 29, 2006, Modern Technology executed an agreement whereby Modern Technology would spin-off Inmarketing in order for it to be a stand-alone public company.
The spin-off process will be completed within 6 months from the date of execution of the agreement. MODC will cause to be filed all appropriate filings with the SEC to effect the spin-off. The spin-off will eliminate over $2,000,000 in debt and contingent liabilities: $750,000 in convertible debt and $1.21 Million convertible preferred stock. Anthony Welch, Chairman, said: ``As promised, we are declaring a stock dividend, creating a new public company for stockholders and further eliminating liabilities. This transaction continues our previously announced plans for profits and debt reduction. The spin-off of Inmarketing brings our reduction of debt and other liabilities to over $3,000,000 for this year alone. These efforts allow us to focus carefully on our new operational unit, Insight Medical Group and its AnuCyte cancer detection system. Shareholders should expect regular updates on our progress as we bring this incredible new technology to market.'
The company will focus its initial efforts in the following major areas of cancer diagnostics:
Prostate Cancer Diagnosis
Prostate tumors with an intermediate histological grade, which represent the majority of prostate tumors, cannot be reliably determined by current clinical laboratory methods. The AnuCyte system rapidly and accurately tests for prostate cancer. The system's results provide the only clinically useful prognostic information for patients with these intermediate grade tumors.
There are approximately 2 million men living with prostate cancer in the USA, with a growth rate of about 200,000 new cases per year. Based on these figures, the company projects prostate cancer diagnostics revenues of $12 million the first year for the market and over $50 million by the end of the third year.
Cervical cancer diagnosis
Currently, cervical cancer represents a larger market than prostate cancer with 55 million Pap smears collected in the USA annually. The company's entry into this market space will be the competition free market of 2-5 million (and rising) ``ASCUS' (indeterminate) Pap smears generated annually.
The AnuCyte system is the only system in the world that measures aneuploidy in cervical smears. This measurement is an independent predictor of biological outcome and will sort out the non-cancerous cells, precancerous cells, and cancerous cells in the ASCUS slide's cell population. There is no method at present in clinical laboratories for deciding the status of an ASCUS slide. The AnuCyte system can quickly deliver comprehensive and accurate results for any ASCUS slide. This puts the ASCUS market in the USA at $200-$500 million annually. The company projects cervical cancer diagnostics revenues of $16 million the first year for the market and $50 million by the end of the third year.
Overall Cancer Diagnostic Marketplace
The worldwide market potential is unquantifiable. The 'AnuCyte Cancer Detection System' is not limited to the cancers mentioned above. The system functions for any slide preparation and delivers rapid and accurate results in all suspected cancerous samples. It must be noted that our predictions only cover the USA market. The international market is much larger and will be part of the company's initial marketing efforts alongside the USA.
About the AnuCyte Cancer Detection System
AnuCyte is the only system in the world that can detect all cancers by analyzing the single trait common to all forms of cancer. This trait is not found in any healthy cell. The system rapidly and accurately identifies cancer at any stage in its development and also identifies healthy cancer-free cells in the same test. The system is unique in the world and can be applied to any form of cell sample suspected of cancer and return a reliable test result within minutes. The system completely eliminates heretofore unreliable, subjective, and error-prone pathology diagnosis of cancer and delivers an automated and completely objective measurement of the presence or absence of cancer with the highest accuracy rate of any diagnostic technology in the world. The AnuCyte system is the first and only system in the world that can accurately detect and assess the chromosomal imbalance of cancer in any tissue sample. This ability allows the system to quickly and accurately identify both cancerous and non-cancerous cells.
The inventor of the AnuCyte system, Dr. David Rasnick, Ph.D. and his scientific research collaborator, Dr. Peter Duesberg, Ph.D., have been prominent names internationally for many years for their research and publications. Investors may wish to read a recent article in Newsweek concerning the cancer research of Dr. Duesberg: http://www.msnbc.msn.com/id/14757547/site/newsweek/
About Insight Medical Group
Insight Medical Group is a specialized biosciences development company whose mission is to bring world-changing medical technology and research to market in the areas of cancer and AIDS. The AnuCyte Cancer Detection System was invented by Dr. David Rasnick, Ph.D. The technology behind AnuCyte and the chromosomal imbalance theory is the result of 45 years of combined cancer research by Dr. David Rasnick, Ph.D. and Dr. Peter Duesberg, Ph.D., who continues his studies on cancer research at the University of California, Berkeley.
About Modern Technology Corp
Modern Technology Corp, a diversified technology development and acquisition company, builds revenues through continuous growth, strategic acquisitions, and commercialization of nascent technology. MODC improves operating efficiencies through the elimination of cost redundancies and realized synergy between subsidiaries. MODC is a fully-reporting public company with the U.S. Securities and Exchange Commission. For more information on the company's SEC filings, visit http://www.sec.gov. The company's web address is: http://www.moderntechnologycorp.com
Safe-Harbor Statement
This press release contains statements (such as projections regarding future performance) that are forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those projected as a result of certain risks and uncertainties, including but not limited to those detailed from time to time in the Company's filings with the Securities and Exchange Commission.
Contact:
Modern Technology Corp
Investor Relations
Anthony Welch
(601) 213-3629
ir@moderntechnologycorp.com
MODC Press Release Source: Modern Technology Corp
Modern Technology Corp Announces Stock-Dividend and Subsidiary Spin-Off
Monday December 4, 10:53 am ET
OXFORD, Miss., Dec. 4, 2006 (PRIME NEWSWIRE) -- Modern Technology Corp (Other OTC:MODC.PK - News), a diversified technology development and acquisition company, announced today its stock dividend date and details of it planned spin-off of its subsidiary, Inmarketing Group.
Stock Dividend:
On January 5th, 2007, all shareholders of record will receive shares in Inmarketing, pro rata, to their ownership in MODC. Stockholders will retain all current ownership in MODC and will receive new shares in Inmarketing in proportion to their ownership in MODC.
Spin-Off:
On Wednesday, Nov 29, 2006, Modern Technology executed an agreement whereby Modern Technology would spin-off Inmarketing in order for it to be a stand-alone public company.
The spin-off process will be completed within 6 months from the date of execution of the agreement. MODC will cause to be filed all appropriate filings with the SEC to effect the spin-off. The spin-off will eliminate over $2,000,000 in debt and contingent liabilities: $750,000 in convertible debt and $1.21 Million convertible preferred stock. Anthony Welch, Chairman, said: ``As promised, we are declaring a stock dividend, creating a new public company for stockholders and further eliminating liabilities. This transaction continues our previously announced plans for profits and debt reduction. The spin-off of Inmarketing brings our reduction of debt and other liabilities to over $3,000,000 for this year alone. These efforts allow us to focus carefully on our new operational unit, Insight Medical Group and its AnuCyte cancer detection system. Shareholders should expect regular updates on our progress as we bring this incredible new technology to market.'
The company will focus its initial efforts in the following major areas of cancer diagnostics:
Prostate Cancer Diagnosis
Prostate tumors with an intermediate histological grade, which represent the majority of prostate tumors, cannot be reliably determined by current clinical laboratory methods. The AnuCyte system rapidly and accurately tests for prostate cancer. The system's results provide the only clinically useful prognostic information for patients with these intermediate grade tumors.
There are approximately 2 million men living with prostate cancer in the USA, with a growth rate of about 200,000 new cases per year. Based on these figures, the company projects prostate cancer diagnostics revenues of $12 million the first year for the market and over $50 million by the end of the third year.
Cervical cancer diagnosis
Currently, cervical cancer represents a larger market than prostate cancer with 55 million Pap smears collected in the USA annually. The company's entry into this market space will be the competition free market of 2-5 million (and rising) ``ASCUS' (indeterminate) Pap smears generated annually.
The AnuCyte system is the only system in the world that measures aneuploidy in cervical smears. This measurement is an independent predictor of biological outcome and will sort out the non-cancerous cells, precancerous cells, and cancerous cells in the ASCUS slide's cell population. There is no method at present in clinical laboratories for deciding the status of an ASCUS slide. The AnuCyte system can quickly deliver comprehensive and accurate results for any ASCUS slide. This puts the ASCUS market in the USA at $200-$500 million annually. The company projects cervical cancer diagnostics revenues of $16 million the first year for the market and $50 million by the end of the third year.
Overall Cancer Diagnostic Marketplace
The worldwide market potential is unquantifiable. The 'AnuCyte Cancer Detection System' is not limited to the cancers mentioned above. The system functions for any slide preparation and delivers rapid and accurate results in all suspected cancerous samples. It must be noted that our predictions only cover the USA market. The international market is much larger and will be part of the company's initial marketing efforts alongside the USA.
About the AnuCyte Cancer Detection System
AnuCyte is the only system in the world that can detect all cancers by analyzing the single trait common to all forms of cancer. This trait is not found in any healthy cell. The system rapidly and accurately identifies cancer at any stage in its development and also identifies healthy cancer-free cells in the same test. The system is unique in the world and can be applied to any form of cell sample suspected of cancer and return a reliable test result within minutes. The system completely eliminates heretofore unreliable, subjective, and error-prone pathology diagnosis of cancer and delivers an automated and completely objective measurement of the presence or absence of cancer with the highest accuracy rate of any diagnostic technology in the world. The AnuCyte system is the first and only system in the world that can accurately detect and assess the chromosomal imbalance of cancer in any tissue sample. This ability allows the system to quickly and accurately identify both cancerous and non-cancerous cells.
The inventor of the AnuCyte system, Dr. David Rasnick, Ph.D. and his scientific research collaborator, Dr. Peter Duesberg, Ph.D., have been prominent names internationally for many years for their research and publications. Investors may wish to read a recent article in Newsweek concerning the cancer research of Dr. Duesberg: http://www.msnbc.msn.com/id/14757547/site/newsweek/
About Insight Medical Group
Insight Medical Group is a specialized biosciences development company whose mission is to bring world-changing medical technology and research to market in the areas of cancer and AIDS. The AnuCyte Cancer Detection System was invented by Dr. David Rasnick, Ph.D. The technology behind AnuCyte and the chromosomal imbalance theory is the result of 45 years of combined cancer research by Dr. David Rasnick, Ph.D. and Dr. Peter Duesberg, Ph.D., who continues his studies on cancer research at the University of California, Berkeley.
About Modern Technology Corp
Modern Technology Corp, a diversified technology development and acquisition company, builds revenues through continuous growth, strategic acquisitions, and commercialization of nascent technology. MODC improves operating efficiencies through the elimination of cost redundancies and realized synergy between subsidiaries. MODC is a fully-reporting public company with the U.S. Securities and Exchange Commission. For more information on the company's SEC filings, visit http://www.sec.gov. The company's web address is: http://www.moderntechnologycorp.com
Safe-Harbor Statement
This press release contains statements (such as projections regarding future performance) that are forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those projected as a result of certain risks and uncertainties, including but not limited to those detailed from time to time in the Company's filings with the Securities and Exchange Commission.
Contact:
Modern Technology Corp
Investor Relations
Anthony Welch
(601) 213-3629
ir@moderntechnologycorp.com
If anyone whats to know why a post was deleted please feel free to ask. There are only 2 reasons why
1) personal attack
2) off topic
and if you what to dispute a removal please contact the moderator of IHUB
http://www.investorshub.com/boards/profile.asp?user=2744
To all board readers,
This board has been without a active moderator, I have asked Matt to let me replace jcinvestny and once again moderate this board, I have recently bought back in. I am going to ask everyone to please from this post forward to stick to the topic of TRBY and no personal attacks.
Thank you
You voted for
Ramesh Pandey
who has received
8536 votes
to date.
Scottrade is allowing buys
thanks for posting that, not to many of us left here
jgbuz
MODC Press Release Source: Modern Technology Corp
Modern Technology Corp Issues Stockholder and Operations Update and Announces Planned Stock Dividend
Friday December 1, 12:36 pm ET
OXFORD, Miss., Dec. 1, 2006 (PRIME NEWSWIRE) -- Modern Technology Corp (Other OTC:MODC.PK - News), a diversified technology development and acquisition company, released today a stockholder and operations update and its plans to declare a stock dividend.
Dividends:
We intend to declare a stock dividend within the next week. We will disclose details of the stock dividend related to our planned spin-off of our subsidiary, Inmarketing Group, in a Form 8-K filing with the SEC and a Press Release.
In 2004, the company paid a $383,697 cash dividend.
The company has paid stock dividends in addition to cash dividends. In October of 2001, we distributed a stock dividend of 403,000 shares in our portfolio company, Scientio, as part of a spin-off transaction. As of June 30, 1999, we distributed a stock dividend of 403,000 shares in our portfolio company, Coral Development Corp., as part of a spin-off transaction.
We intend to continue paying dividends as appropriate and as part of our anticipated subsidiary spin-off strategy. As we mature and grow our portfolio companies, it is only natural that a public spin-off transaction be considered. Each stockholder in MODC would receive stock in the new public spin-off company in addition to stock they already own in MODC. Our long-term plan is for stockholders to realize strong capital appreciation from their MODC stock as well as the appreciation of stock in the spin-off transactions.
Quarterly Results:
During the three months ending September 30, 2006, we generated revenues of $3,085,878 versus $1,311,779 for the three months ended September 30, 2005, an increase of 235%. We also reported assets of $4,774,355. For complete details, please visit the SEC's website at http://www.sec.gov.
Anthony Welch, Chairman, said: ``As promised, we will be declaring stock dividend. Details of this will be released next week and a dividend date set and disclosed in the appropriate regulatory filings. Concurrently with this stock dividend and spin off transaction, we will be launching Insight Medical Group into the cancer diagnostics market. Insight's website and related materials will be released to the public as part of this launch. The marketing team, laboratory set up, and system set up are all well underway.
``We feel our revenue results to date will pale in comparison to our revenue resulting from the AnuCyte system. The AnuCyte system will be patented internationally as soon as practicable to protect long term stockholder interest. Insight's cancer detection system is without any doubt or hesitation in stating, the single most accurate cancer detection technology in the world. Using a tissue sample it can detect any type of cancer. No other diagnostic system can even remotely approach this capability or accuracy.
``We stand ready to defend this claim with direct testing comparisons of all existing approaches to cancer diagnostics. The implications of this fact are staggering and we have little doubt AnuCyte will quickly become the de facto 'gold' standard for cancer diagnostics. We have a lot of exciting things to report regarding AnuCyte and Insight Medical. We will be releasing regular stockholder updates on this incredible new business unit.''
More about the cancer diagnostic marketplace:
Prostate Cancer Diagnosis
Prostate tumors with an intermediate histological grade, which represent the majority of prostate tumors, cannot be reliably determined by current clinical laboratory methods. The AnuCyte system can rapidly and accurately test for prostate cancer. The system's test results provide the only clinically useful prognostic information for patients with these intermediate grade tumors.
There are approximately 2 million men living with prostate cancer in the U.S., with a growth rate of about 200,000 new cases per year. Based on these figures, the company projects prostate cancer diagnostics revenues of $12 million the first year for the market and over $50 million by the end of the third year.
Cervical cancer diagnosis
Currently, cervical cancer represents a larger market than prostate cancer with 55 million Pap smears collected in the U.S. annually. The company's entry into this market space will be the competition free market of 2-5 million (and rising) ``ASCUS'' (indeterminate) Pap smears generated annually.
The AnuCyte system is the only system in the world that measures aneuploidy in cervical smears. This measurement is an independent predictor of biological outcome and will sort out the non-cancerous cells, precancerous cells, and cancerous cells in the ASCUS slide's cell population. There is no method at present in clinical laboratories for deciding the status of an ASCUS slide. The AnuCyte system can quickly deliver comprehensive and accurate results for any ASCUS slide. This puts the ASCUS market in the USA at $200-$500 million annually. The company projects cervical cancer diagnostics revenues of $16 million the first year for the market and $50 million by the end of the third year.
Overall Cancer Diagnostic Marketplace
The worldwide market potential is unquantifiable. The 'AnuCyte Cancer Detection System' is not limited to the cancers mentioned above. The system functions for any slide preparation and delivers rapid and accurate results in all suspected cancerous samples. It must be noted that our predictions only cover the USA market. The international market is much larger and will be part of the company's initial marketing efforts alongside the USA.
About the AnuCyte Cancer Detection System
AnuCyte is the only system in the world that can detect all cancers by analyzing the single trait common to all forms of cancer. This trait is not found in any healthy cell. The system rapidly and accurately identifies cancer at any stage in its development and also identifies healthy cancer-free cells in the same test. The system is unique in the world and can be applied to any form of cell sample suspected of cancer and return a reliable test result within minutes. The system completely eliminates heretofore unreliable, subjective, and error-prone pathology diagnosis of cancer and delivers an automated and completely objective measurement of the presence or absence of cancer with the highest accuracy rate of any diagnostic technology in the world. The AnuCyte system is the first and only system in the world that can accurately detect and assess the chromosomal imbalance of cancer in any tissue sample. This ability allows the system to quickly and accurately identify both cancerous and non-cancerous cells.
The inventor of the AnuCyte system, Dr. David Rasnick, PhD and his scientific research collaborator, Dr. Peter Duesberg, PhD, have been prominent names internationally for many years for their research and publications. Investors may wish to read a recent article in Newsweek concerning the cancer research of Dr. Duesberg:
http://www.msnbc.msn.com/id/14757547/site/newsweek/
About Insight Medical Group
Insight Medical Group is a specialized biosciences development company whose mission is to bring world-changing medical technology and research to market in the areas of cancer and AIDS. The AnuCyte Cancer Detection System was invented by Dr. David Rasnick, PhD. The technology behind AnuCyte and the chromosomal imbalance theory is the result of 45 years of combined cancer research by Dr. David Rasnick, PhD and Dr. Peter Duesberg, PhD, who continues his studies on cancer research at the University of California, Berkeley.
About Modern Technology Corp
Modern Technology Corp, a diversified technology development and acquisition company, builds revenues through continuous growth, strategic acquisitions, and commercialization of nascent technology. MODC improves operating efficiencies through the elimination of cost redundancies and realized synergy between subsidiaries. MODC is a fully-reporting public company with the US Securities and Exchange Commission. For more information on the company's SEC filings, visit http://www.sec.gov. The company's web address is: http://www.moderntechnologycorp.com
Safe-Harbor Statement
This press release contains statements (such as projections regarding future performance) that are forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those projected as a result of certain risks and uncertainties, including but not limited to those detailed from time to time in the Company's filings with the Securities and Exchange Commission.
Contact:
Modern Technology Corp
Investor Relations:
Anthony Welch
(601) 213 3629
ir@moderntechnologycorp.com
--------------------------------------------------------------------------------
list of countries with extradition treaties
http://en.wikipedia.org/wiki/List_of_United_States_extradition_treaties
Rufus is on sub penny rebroadcast NOW
exactly, rufus should be on any minute, I'll let you know, if your not listening already
this is some great entertainment
Could Tony on A&E bring restrictions to cable?
Posted 12/1/2006 3:17 AM ET
By David Lieberman, USA TODAY
NEW YORK — When HBO introduced The Sopranos in 1999, critics applauded the smartly crafted stories about a modern-day crime family. They saw the obscenities, sex, nudity and violence as part of what made it so realistic.
But it's unclear how audiences will react beginning Jan. 10 when a version of the series moves from the 30 million homes paying a premium to get HBO to the 90 million that get A&E Network in their basic cable TV package. Some of the more graphic elements have been edited out, but it may still cause a stir.
That's because an army of fed-up parents and lawmakers already are making an issue of what they see as the spread of child-unfriendly programming on basic cable that has followed the success of taboo-breaking basic cable shows including FX's The Shield, Rescue Me and Nip/Tuck, Comedy Central's South Park and MTV's annual Spring Break.
"There are cable network programmers whose clear and sole objective is to break any boundary without regard for what the consequences are for society," says Parents Television Council Executive Director Tim Winter. Some shows, he says, have glamorized rape, pedophilia, incest, racism and misogyny.
The risk cable now faces is that if edgy shows such as The Sopranos lead many more people to conclude that Winter is right, that could result in government restrictions for these basic networks, which now largely regulate themselves. Although such a change would raise free-speech questions, critics say that the fact that 86% of all homes get TV via cable or satellite services makes basic cable and broadcast programming virtually indistinguishable. About 60% of adults endorsed programming standards for basic cable in a recent Pew Research Center survey.
"You're hearing the tom-toms beating in Washington," says Henry Schleiff, CEO of Crown Media, which owns the Hallmark Channel. "The risk is that we are subjecting ourselves to potential regulation from the Federal Communications Commission or Congress. That's a very, very big thing."
Congress last year considered letting the FCC apply the kinds of rules for obscene or indecent programming on basic cable the way it now regulates broadcasters that use the public airwaves, including ABC, CBS, Fox and NBC (see box).
An alternative approach, favored by FCC Chairman Kevin Martin, would require cable and satellite to offer basic channels on a so-called a la carte basis instead of in all-or-nothing packages. That way, programmers could air what they want, and consumers could judge — and buy — each channel individually the same way they can now with premium channels such as HBO. That's an approach cable operators say would kill off many smaller and specialized channels.
These crosscurrents forced A&E to painstakingly edit The Sopranos. It couldn't be so bland that it would turn off the young adult viewers that advertisers covet, viewers the network must win to justify the record $2.5 million it is paying for each of the 78 episodes.
"We do not want to be the people who ruined The Sopranos," says Dawn Porter, A&E vice president of standards and practices. But A&E had to do something to escape the wrath of anti-smut activists who might target it and its advertisers.
"Generally, I would say, 'Come on, it's an adult show,' " general manager Bob DeBitetto says. But of the final edit, he adds: "When I look at … so much that's on television elsewhere already, I mean, my goodness, we're so well within that."
No easy choices
The state of the cable business isn't making the choices easier. Established, general entertainment channels know if they don't air attention-grabbing shows, including some that anger parents, they risk becoming irrelevant. The days of double-digit growth appear to be over for many ad-supported basic channels. Non-premium network revenue likely will hit $37.9 billion this year, with annual growth slowing from 16.8% in 2004 to 7.5% in 2010, according to PricewaterhouseCoopers.
And these numbers understate the issue for older, general entertainment networks. Prime-time ratings fell 1.7% in the first three quarters of 2006 vs. the period last year at the 36 largest cable networks. The average home now gets 95 channels, up from 77 in 2000.
"The environment has gotten a lot more competitive because there are a lot more options: (regular) channels, video on demand, video on broadband," says David Zaslav, who is NBC Universal's president of cable and domestic TV and new media distribution and will become CEO of Discovery Communications early next year. "To reach viewers, you have to be clear about what you are in your niche."
Many executives are backing away from offering mainly reruns of broadcasters' hit sitcoms and dramas. "Outside of Law & Order, there aren't a lot of (rerun) series that have really boosted a cable network," Schleiff says. "NYPD Blue didn't do much for Court TV," which Schleiff ran before moving to Crown.
One solution has been for channels to produce their own shows. FX showed how that could pay off beginning in 2002 when it introduced The Shield. That show, plus Nip/Tuck and Rescue Me added later, helped lift FX from the No. 12 cable network in prime time for prized 18- to 49-year-olds in 2001 to No. 5 this year. The Shield, starring Michael Chiklis as an anti-hero cop, "was the first of these high-quality, scripted, highly successful dramas on basic cable," FX President John Landgraf says.
In response to cultural critics shocked by The Shield's fascination with torture and sexual violence, Landgraf says the widely acclaimed show is for adults, it carries a warning about its graphic content and it airs at 10 p.m. ET. Still, Nielsen ratings show 5.2% of the average 2 million viewers per show over the last year were under age 17, including 2.4% under 11.
"Post-10 p.m. has been deemed since time immemorial … an adult viewing hour," Landgraf says. "Even though we're under no obligation to abide by that standard (as broadcasters are), we've abided by it voluntarily because we think it's responsible." The network also discovered with The Shield and its other graphic shows that there are secondary revenue sources. "There is an incredible appetite for (the series) overseas," Landgraf says. "They also do well on DVD. … I recently looked at a list of television DVDs, and we had four of the top 20."
Other channels caught on, and also pushed the edge. "Even a show like (Sci-Fi Channel's) Battlestar Galactica has pushed the envelope further than you'd see on a broadcast network: more graphic scenes of violence, some sexual content," says Larry Gerbrandt at Nielsen Analytics. "It's a darker vision."
Premium reruns
Along with more original productions, basic cable channels have taken a new look at the potential in reruns of hits from premium channels. Besides A&E's deal with HBO for The Sopranos, Bravo picked up its Six Feet Under and TBS got Sex and the City.
The cable industry says it can help parents who don't want their kids to see such fare. Late last year, the major operators introduced, as an alternative to basic cable packages, bundles of only kid-friendly channels. Comcast, Time Warner and Cox declined to say how many homes signed up. The industry also beefed up marketing to tell parents how their TV sets, cable boxes or DVRs can block certain shows or channels. "We've done some great campaigns on that," Zaslav says. "We have a rating system that provides real clarity."
Even the slickest technology can't help, though, when channels don't synchronize programs with ads. For example, DVR owners who recently recorded late-night airings of Spike TV's The Three StoogesSlap-Happy Hour — rated PG, meaning OK for 8-year-olds — might have been surprised to see ads for DVDs of Girls Gone Wild: Ultimate Rush. Spike TV's parent, MTV Networks, wouldn't address the specific example, but said in a statement: "We restrict mature content to late-night hours."
Cultural critics say the focus on blocking misses the point. So do federal rules. They want the freedom to subscribe to channels individually so they don't subsidize shows that they say coarsen the culture. Basic cable channels have two sources of revenue: ad sales and a fee from the cable operator for each subscriber to the basic package. "You're seeing exponential growth in this stuff," Winter says. "If it weren't for the forced bundles, this could not perpetuate."
And channels that trim graphic scenes still "help to legitimize the more vulgar stuff" and "allow advertisers to get comfortable" with the shows, he says.
The problem A&E faced a few years ago, though, was that advertisers were turned off by viewers who tuned in to shows such as Murder, She Wrote. "With a 61 median age, we were outside even the older of the valuable demos," DeBitetto says. In 2004, A&E began to chase younger viewers, and "We had to do something that was scary, which was to fairly rudely … show our loyal viewership the door."
The Sopranos is key to that effort. "This is certainly going to change A&E," says Kagan Media's Deana Myers. "It gets them talked about."
A&E says the edited versions will be rated TV-14 (some episodes will include labels indicating strong language or violence) and will air Wednesday nights, with repeats on Mondays, at 9 p.m. ET.
Little had to be cut, Porter says. "Our little secret is that it wasn't as hard as people think it is." The first two seasons presented the biggest challenges. Producers didn't expect the show to become such a big hit and didn't film less-graphic versions of key scenes. A&E got around some of those problems by using footage from the cutting-room floor and soundtracks with the actors replacing profanities.
Violence was "by far the easiest" element to address, DeBitetto says, because shows such as The Shield have redefined what's acceptable. More troublesome were naked dancers in the background of key scenes. "We were able to pull the frame in a little bit so maybe you see the girls' legs but not the naughty bits."
The bottom line, though: "It's an adult show. Surely, people would want to exercise discretion."
But pretty soon, even The Sopranos might seem tame. "There's absolutely no reason the episodes that are on A&E could not air on local television stations," says Scott Carlin, HBO's president of domestic programming distribution. If A&E hadn't bought the show, "We would have had a pretty easy time syndicating The Sopranos around the country."
the replay is on sub penny radio, not sure what time rufus will be on
you are better than Madden & Michaels calling a football game
thanks for the play calling
if Rufus can't own it , I think he is going to try to destroy it
roach is just to good, maybe if we add him to the team, we can take credit for it......................
LOL
roach you are always welcome,
U.S. warns of possible Qaeda financial cyber attack Thu Nov 30, 6:33 PM ET
WASHINGTON (Reuters) - The U.S. government has warned U.S. private financial services of an al Qaeda call for a cyber attack against U.S. online stock trading and banking Web sites beginning Friday, officials said on Thursday.
The officials -- a person familiar with the warning and a spokesman for the Department of Homeland Security -- said the Islamic militant group aimed to penetrate and destroy the databases of the U.S. stock market and banking Web sites.
Homeland Security said it had no evidence to corroborate the threat but had issued the warning out of an "abundance of caution." The department said in a statement that the threat was for all of December.
"There is no information to corroborate this aspirational threat. As a routine matter and out of an abundance of caution, US-CERT issued the situational awareness report to industry stakeholders," said Homeland Security spokesman Russ Knocke.
US-CERT is the U.S. Computer Emergency Readiness Team. The U.S. government said the threat was to avenge the holding of suspected terrorists at the U.S. prison in Guantanamo.
U.S. warns of possible Qaeda financial cyber attack Thu Nov 30, 6:33 PM ET
WASHINGTON (Reuters) - The U.S. government has warned U.S. private financial services of an al Qaeda call for a cyber attack against U.S. online stock trading and banking Web sites beginning Friday, officials said on Thursday.
The officials -- a person familiar with the warning and a spokesman for the Department of Homeland Security -- said the Islamic militant group aimed to penetrate and destroy the databases of the U.S. stock market and banking Web sites.
Homeland Security said it had no evidence to corroborate the threat but had issued the warning out of an "abundance of caution." The department said in a statement that the threat was for all of December.
"There is no information to corroborate this aspirational threat. As a routine matter and out of an abundance of caution, US-CERT issued the situational awareness report to industry stakeholders," said Homeland Security spokesman Russ Knocke.
US-CERT is the U.S. Computer Emergency Readiness Team. The U.S. government said the threat was to avenge the holding of suspected terrorists at the U.S. prison in Guantanamo.
updated message 29
chart in IBOX from stock charts, our messages were answered, are the indicators I use OK, stochRSI,CMF and MACD 12,26.9 or do you like other let me know
jgbuz
were is Here comes the night, I heard a rumor that he's pumping this on RB, been trying to find out his alias on RB
stocks I'll take Houston
Symbol Request Completed
Your symbol request for [ONYI] has been submitted to the StockCharts.com Support team. We will email you once it has been added to StockCharts.com.
skeen have you been able to make a chart for ONYI on stock charts, I can't, would like to put one in the IBOX, but it says no such ticker symbol
jgbuz
Its similar but not the same, this is a statement from the 11/09 pr which you may be referring to
Because the company is ahead of schedule, it will build a second A70 plant instead of laying-off workers until construction of the A500 begins on January 3, after a real estate closing.
The company will begin assembling the second A70 plant, which it anticipates it will use for research and development for cellulose and fruit waste research and development. The company expects the new A70 to take much less time to build
you can look in the ibox for all the latest PRs
ONYI Press Release Source: Diversified Ethanol
Diversified Ethanol Has a New Ethanol Plant Planned for Construction
Monday November 27, 4:52 pm ET
CHICAGO--(BUSINESS WIRE)--The new Diversified Ethanol (OCTBB:ONYI) plant is the new A500 model that will produce up to 500,000 gallons (2,000,000 liters) per year.
This plant will cost $1,600,000 (1,200,000 Euros). In addition to the sales price, Diversified Ethanol (O.N.Y.I) offers an optional guaranteed service and maintenance contract for a percentage of the profit of operation, which would increase long term income, where plants are sold to other companies.
The A500 is tentatively scheduled to start construction on January 3, 2007, which is ahead of initial company projections.
This new A500 plant has the potential to produce a minimum of 500,000 gallons of ethanol per year.
An ethanol plant valuation, for sale, is usually 5 times annual revenues. This gives a potential market value of $2,500,000 (1,900,000 Euros) for resale once a plant is completed and fully operational.
Most publicly traded companies trade at 17.6 times their annual earnings, but Ethanol Companies, due to the potential growth of the industry, historically trade at much higher price to earnings multiples.
A dramatic increase in demand for ethanol plants has taken place since the U.S. Government's mandate to double the ethanol content in gasoline, from 20 Billion liters per year to 40 Billion liters per year in the United States.
The A500 plants are designed by Floyd Butterfield, Diversified Ethanol's Chief Designer, who has been awarded honors for his past projects. These plants will include all of his updated features.
Diversified Ethanol's CEO, Taylor Moffitt, said, "We hope to produce the A500 quickly...and keep it for long term earnings or sell it for a quick profit, or both."
This press release does not constitute an offer of any securities for sale. This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements involve certain risks and uncertainties that could cause actual results to differ, including, without limitation, the company's limited operating history and history of losses, the inability to successfully obtain further funding, the inability to raise capital on terms acceptable to the company, the inability to compete effectively in the marketplace, the inability to complete the proposed acquisition and such other risks that could cause the actual results to differ materially from those contained in the company's projections or forward-looking statements. All forward-looking statements in this press release are based on information available to the company as of the date hereof, and the company undertakes no obligation to update forward-looking statements to reflect events or circumstances occurring after the date of this press release.
Contact:
Diversified Ethanol
Chris McGovern, 515-603-6292
--------------------------------------------------------------------------------
Source: Diversified Ethanol
Press Release Source: Diversified Ethanol
Diversified Ethanol Has a New Ethanol Plant Planned for Construction
Monday November 27, 4:52 pm ET
CHICAGO--(BUSINESS WIRE)--The new Diversified Ethanol (OCTBB:ONYI) plant is the new A500 model that will produce up to 500,000 gallons (2,000,000 liters) per year.
This plant will cost $1,600,000 (1,200,000 Euros). In addition to the sales price, Diversified Ethanol (O.N.Y.I) offers an optional guaranteed service and maintenance contract for a percentage of the profit of operation, which would increase long term income, where plants are sold to other companies.
The A500 is tentatively scheduled to start construction on January 3, 2007, which is ahead of initial company projections.
This new A500 plant has the potential to produce a minimum of 500,000 gallons of ethanol per year.
An ethanol plant valuation, for sale, is usually 5 times annual revenues. This gives a potential market value of $2,500,000 (1,900,000 Euros) for resale once a plant is completed and fully operational.
Most publicly traded companies trade at 17.6 times their annual earnings, but Ethanol Companies, due to the potential growth of the industry, historically trade at much higher price to earnings multiples.
A dramatic increase in demand for ethanol plants has taken place since the U.S. Government's mandate to double the ethanol content in gasoline, from 20 Billion liters per year to 40 Billion liters per year in the United States.
The A500 plants are designed by Floyd Butterfield, Diversified Ethanol's Chief Designer, who has been awarded honors for his past projects. These plants will include all of his updated features.
Diversified Ethanol's CEO, Taylor Moffitt, said, "We hope to produce the A500 quickly...and keep it for long term earnings or sell it for a quick profit, or both."
This press release does not constitute an offer of any securities for sale. This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements involve certain risks and uncertainties that could cause actual results to differ, including, without limitation, the company's limited operating history and history of losses, the inability to successfully obtain further funding, the inability to raise capital on terms acceptable to the company, the inability to compete effectively in the marketplace, the inability to complete the proposed acquisition and such other risks that could cause the actual results to differ materially from those contained in the company's projections or forward-looking statements. All forward-looking statements in this press release are based on information available to the company as of the date hereof, and the company undertakes no obligation to update forward-looking statements to reflect events or circumstances occurring after the date of this press release.
Contact:
Diversified Ethanol
Chris McGovern, 515-603-6292
--------------------------------------------------------------------------------
Source: Diversified Ethanol
You voted for
Ramesh Pandey
who has received
4824 votes